ACAD - Company ID 0001070494
ACADIA PHARMACEUTICALS INC (ACAD) reported revenue of $1.07B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $1.07B | +11.9% |
| FY 2024 | $957.80M | +31.8% |
| FY 2023 | $726.44M | +40.4% |
| FY 2022 | $517.24M | +6.8% |
| FY 2021 | $484.14M | +9.6% |
| FY 2020 | $441.75M | +30.3% |
| FY 2019 | $339.08M | +51.5% |
| FY 2018 | $223.81M | +79.2% |
| FY 2017 |
ACADIA PHARMACEUTICALS INC (ACAD) reported revenue of $1.07B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, ACADIA PHARMACEUTICALS INC's revenue grew from $2.07M to $1.07B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $124.90M |
| +620.7% |
| FY 2016 | $17.33M | +28311.5% |
| FY 2015 | $61.00K | -49.2% |
| FY 2014 | $120.00K | -89.5% |
| FY 2013 | $1.15M | -76.7% |
| FY 2012 | $4.91M | +137.4% |
| FY 2011 | $2.07M | - |